Development and Validation RP-HPLC Method for Simultaneous Estimation of Bilastine and Montelukast in Bulk and Pharmaceutical Dosage Form

Authors

  • Syed Nizamuddin Department of Pharmaceutical Analysis, RR College of Pharmacy, Bengaluru, Karnataka, India
  • S. Appala Raju Department of Pharmaceutical Analysis, HKE’s College of Pharmacy, Gulbarga, Karnataka, India

DOI:

https://doi.org/10.21276/apjhs.2022.9.3.49

Keywords:

Bilastine, Montelukast, Simultaneous estimation, Validation

Abstract

A simple, precise, sensitive, and rapid reverse phase high-performance liquid chromatography method was developed and validated for simultaneous estimation of bilastine and montelukast in bulk as well as in tablet formulation according to ICH guidelines. The chromatographic phase consisted by methanol and acetonitrile (70:30) at pH 3 adjusted by 0.1% orthophosphoric acid. The flow rate was adjusted to 1 ml/min and ultraviolet detection was carried out at 260 nm. The retention time for of bilastine and montelukast were found to be 3 and 7 min, respectively. The detector was showed linear responses over the concentration range 25–150 μg/ml for bilastine and 5–30 μg/ml for montelukast a good correlation coefficient of 0.999. This proposed method is highly sensitive, precise, and accurate which reduces cost of analysis, hence recommended for routine quality analysis in laboratories.

Downloads

Download data is not yet available.

Downloads

Published

2022-04-16

How to Cite

Syed Nizamuddin, & S. Appala Raju. (2022). Development and Validation RP-HPLC Method for Simultaneous Estimation of Bilastine and Montelukast in Bulk and Pharmaceutical Dosage Form. Asian Pacific Journal of Health Sciences, 9(3), 242–247. https://doi.org/10.21276/apjhs.2022.9.3.49

Issue

Vol. 9 No. 3 (2022): Vol 9 | Issue 3 | July - September 2022

Section

Articles

License

Copyright (c) 2022 Syed Nizamuddin, S. Appala Raju

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.